Basiliximab (CAS 86541-75-5) Market Research Report 2013 aims at providing comprehensive data on basiliximab market globally and regionally (Europe, Asia, North America, Latin America etc.)
The report includes basiliximab description, covers its application areas, manufacturing methods, patterns. It captures basiliximab market trends, pays close attention to basiliximab manufacturers and names suppliers.
Besides, the report provides basiliximab prices in regional markets.
In addition to the above the report determines basiliximab consumers.
Our specialists can evaluate the following aspects of the market for each chemical product in any country or region:
- present market conditions
- plants’ capacity and production
- consumption volume and structure
- export and import
- market prices trends
- existing technologies an patterns
- raw materials market
- market forecast
- etc.
- basiliximab ranges, trademarks, analogous products, application areas, manufacturing methods
- present basiliximab market conditions, prices
- basiliximab market forecast, estimations
- basiliximab manufacturers, consumers and traders (including contact details)
Basiliximab (CAS 86541-75-5) Market Research Report 2013 contents were worked out and placed on the website in May, 2013. As a special offer the report price was reduced and now is as low as US$ 2,650.00. Do not lose the chance to order this Market Report for almost half-price.
1. BASILIXIMAB: GENERAL INFORMATION
1.1. Properties
1.2. Composition, information on ingredients
1.3. Hazards identification
1.4. Handling and storage
1.5. Toxicological & ecological information
1.6. Transport information
2. BASILIXIMAB END-USE SECTOR
2.1. Application areas
2.2. Patents
3. BASILIXIMAB MARKET WORLDWIDE. MANUFACTURERS AND SUPPLIERS OF BASILIXIMAB (INCLUDING CONTACT DETAILS).
3.1. Manufacturers of basiliximab
3.1.1. Europe
3.1.2. Asia
3.1.3. North America
3.2. Suppliers of basiliximab
3.2.1. Europe
3.2.2. Asia
3.2.3. North America
4. CURRENT BASILIXIMAB MARKET PRICES
4.1. Europe
4.2. Asia
4.3. North America
5. BASILIXIMAB CONSUMERS
*Please note that Basiliximab (CAS 86541-75-5) Market Research Report 2013 is a half ready publication. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. Business Analytic Center (BAC) has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.
| Product Name: | Basiliximab |
|---|---|
| Synonyms: | Benazepril 2-[(4S)-4-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-3-oxo-2-azabicyclo[5.4.0]undeca-7,9,11-trien-2-yl]acetic acid Benazepril Hcl Benazepril Benazapril |
| CAS#: | 86541-75-5 |
| Formula: | C24H28N2O5 |
| Molecular Weight: | 424.49 |
| Structure: |  |
| Usage: | Used to treat hypertension, congestive heart failure, and chronic renal failure. . |